Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes

被引：3

作者：

Sanchez-Castro, Judit ^{[1
]}

Marco-Betes, Victor ^{[1
]}

Gomez-Arbones, Xavier ^{[1
,2
]}

Garcia-Cerecedo, Tomas ^{[1
]}

Lopez, Ricard ^{[1
]}

Talavera, Elisabeth ^{[1
]}

Fernandez-Ruiz, Sara ^{[3
]}

Adema, Vera ^{[3
]}

Marugan, Isabel ^{[4
]}

Luno, Elisa ^{[5
]}

Sanzo, Carmen ^{[5
]}

Vallespi, Teresa ^{[6
]}

Arenillas, Leonor ^{[7
]}

Marco-Buades, Josefa ^{[8
]}

Batlle, Ana ^{[9
]}

Buno, Ismael ^{[10
]}

Luisa Martin-Ramos, Maria ^{[11
]}

Blazquez-Rios, Beatriz ^{[12
]}

Collado-Nieto, Rosa ^{[13
]}

Teresa Vargas, Ma ^{[14
]}

Gonzalez-Martinez, Teresa ^{[15
]}

Sanz, Guillermo ^{[16
]}

Sole, Francesc ^{[3
]}

机构：

[1] Hosp Arnau Vilanova, Lleida, Spain

[2] Univ Lleida, Lleida, Spain

[3] Inst Recerca Leucemia Josep Carreras IJC, Barcelona 08916, Spain

[4] Univ Valencia, Hosp Clin, Valencia, Spain

[5] Hosp Univ Cent Asturias, Oviedo, Spain

[6] Hosp Valle De Hebron, Barcelona, Spain

[7] Hosp del Mar, Barcelona, Spain

[8] Hosp Gen Castellon, Castellon de La Plana, Spain

[9] Hosp Univ Marques Valdecilla, Santander, Spain

[10] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[11] Hosp Univ 12 Octubre, Madrid, Spain

[12] Hosp Basurto, Bilbao, Spain

[13] Hosp Gen Univ Valencia, Valencia, Spain

[14] Hosp Univ Virgen Macarena, Seville, Spain

[15] Hosp Clin Univ, Fdn Publ Galega Med Xenom, Santiago, Spain

[16] Hosp Univ & Politecn La Fe, Valencia, Spain

来源：

LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 11期

关键词：

Myelodysplastic syndromes; cytogenetics; FISH; chromosome; 17; ACUTE MYELOID-LEUKEMIA; PROGNOSTIC SCORING SYSTEM; PREDICTING SURVIVAL; DELETION; MDS; KARYOTYPE;

D O I：

10.3109/10428194.2015.1028053

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Conventional G-banding cytogenetics (CC) detects chromosome 17 (chr17) abnormalities in 2% of patients with de novo myelodysplastic syndromes (MDS). We used CC and fluorescence in situ hybridization (FISH) (LSI p53/17p13.1) to assess deletion of 17p in 531 patients with de novo MDS from the Spanish Group of Hematological Cytogenetics. FISH detected - 17 or 17p abnormalities in 13 cases (2.6%) in whom no 17p abnormalities were revealed by CC: 0.9% of patients with a normal karyotype, 0% in non-informative cytogenetics, 50% of patients with a chr17 abnormality without loss of 17p and 4.7% of cases with an abnormal karyotype not involving chr17. Our results suggest that applying FISH of 17p13 to identify the number of copies of the TP53 gene could be beneficial in patients with a complex karyotype. We recommend using FISH of 17p13 in young patients with a normal karyotype or non-informative cytogenetics, and always in isolated del(17p)

引用

页码：3183 / 3188

页数：6

共 50 条

[1] TP53 in Myelodysplastic Syndromes
Jiang, Yan
Gao, Su-Jun
Soubise, Benoit
Douet-Guilbert, Nathalie
Liu, Zi-Ling
Troadec, Marie-Berengere
CANCERS, 2021, 13 (21)
[2] Targeting TP53 Mutations in Myelodysplastic Syndromes
Hunter, Anthony M.
Sallman, David A.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (02) : 421 - +
[3] Mutation Profile of PPM1D and TP53 in Patients with Myelodysplastic Syndromes and Complex Chromosome Abnormalities
Eder, Lea Naomi
Ganster, Christina
Shirneshan, Katayoon
Germing, Ulrich
Elmaagacli, Ahmet H.
Mies, Anna
Hertenstein, Bernd
Simon-Becker, Susanne
Platzbecker, Uwe
Dierks, Sascha
Rittscher, Katharina
Schaab, Roxana
Martin, Roman
Soeling, Ulrike
Heudobler, Daniel
Lange, Frank
Hildebrandt, Barbara
Glass, Bertram
Braulke, Friederike
Schanz, Julie
Haase, Detlef
BLOOD, 2019, 134
[4] Detection of chromosome 17 aneuplody and TP53 gene deletion in a broad variety of solid tumors by dual-color fluorescence in situ hybridization (FISH)
Carlos Herrera, Juan
Fernando Isaza, Luis
Luis Ramirez, Jose
Vasquez, Gonzalo
Mario Muneton, Carlos
BIOMEDICA, 2010, 30 (03): : 390 - 400
[5] Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53
Siddon, Alexa J.
Weinberg, Olga K.
CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 607 - 614
[6] ASSIGNMENT OF TP53 AND TK1 TO CHROMOSOME-13 IN PEROMYSCUS BY FLUORESCENCE IN-SITU HYBRIDIZATION
WANG, Z
YOUNG, SR
LIU, L
DAWSON, WD
CYTOGENETICS AND CELL GENETICS, 1995, 69 (1-2): : 97 - 100
[7] LOCALIZATION OF THE TP53 GENE ON SYRIAN-HAMSTER CHROMOSOME-9 BY FLUORESCENCE IN-SITU HYBRIDIZATION
POPESCU, NC
ZIMONJIC, DB
ALBOR, A
NOTARIO, V
CYTOGENETICS AND CELL GENETICS, 1995, 68 (1-2): : 71 - 73
[8] Study of chromosome 17 aneuploidy and of TP53 gene deletion in patients with hematological neoplasias by dual-color fluorescence in situ hybridization (FISH)
Herrera Patino, Juan Carlos
Ramirez Gaviria, Gloria Cecilia
Muneton Pena, Carlos Mario
IATREIA, 2008, 21 (04) : 364 - 374
[9] Landscape of TP53 Abnormalities and Their Clinical Relevance in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia
Montalban-Bravo, Guillermo
Benton, Christopher B.
Kanagal-Shamanna, Rashmi
Sasaki, Koji
Assi, Rita
Kadia, Tapan M.
Ravandi, Farhad
Ganan-Gomez, Irene
Cortes, Jorge E.
Daver, Naval G.
Takahashi, Koichi
DiNardo, Courtney D.
Jabbour, Elias J.
Borthakur, Gautam
Pemmaraju, Naveen
Konopleva, Marina Y.
Pierce, Sherry A.
Bueso-Ramos, Carlos E.
Kornblau, Steven M.
Patel, Keyur
Colla, Simona
Kantarjian, Hagop M.
Andreeff, Michael
Garcia-Manero, Guillermo
BLOOD, 2018, 132
[10] NUMBER OF TP53 ABNORMALITIES AND THEIR CLINICAL RELEVANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
Montalban-Bravo, G.
Benton, C.
Kadia, T.
Ravandi, F.
Cortes, J.
Daver, N.
Takahashi, K.
DiNardo, C.
Jabbour, E.
Borthakur, G.
Pemmaraju, N.
Konopleva, M.
Alfonso, A.
Pierce, S.
Bueso-Ramos, C.
Kornblau, S.
Patel, K.
Kantarjian, H.
Andreeff, M.
Garcia-Manero, G.
HAEMATOLOGICA, 2017, 102 : 48 - 48

← 1 2 3 4 5 →